Metformin as a prevention and treatment for preeclampsia: Effects on soluble fms-like tyrosine kinase 1 and soluble endoglin secretion and endothelial dysfunction

American Journal of Obstetrics and Gynecology

Volumn 214, Issue 3, 2016, Pages 356.e1-356.e15

  Brownfoot, Fiona C ^a   Hastie, Roxanne ^a   Hannan, Natalie J ^a   Cannon, Ping ^a   Tuohey, Laura ^a   Parry, Laura J ^a   Senadheera, Sevvandi ^a   Illanes, Sebastian E ^b   Kaitu'U Lino, Tu'Uhevaha J ^a   Tong, Stephen ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSIDAD DE LOS ANDES   (Chile)

Author keywords

electron transport chain; metformin; preeclampsia; soluble endoglin; soluble fms like tyrosine kinase 1

Indexed keywords

BRADYKININ; CITRININ; ENDOGLIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; METFORMIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); ROTENONE; SUCCINATE DEHYDROGENASE (UBIQUINONE); SUCCINIC ACID; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN RECEPTOR 1; BIOLOGICAL MARKER; CARDIOVASCULAR AGENT; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; FLT1 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; MULTIENZYME COMPLEX;

ANGIOGENESIS; ARTICLE; CHORION VILLUS; CONTROLLED STUDY; CYTOTROPHOBLAST; DRUG SAFETY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; PLACENTA; PLACENTA TISSUE; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RESPIRATORY CHAIN; UMBILICAL VEIN ENDOTHELIAL CELL; VASODILATATION; DRUG EFFECTS; IN VITRO STUDY; METABOLISM; PATHOPHYSIOLOGY; PRE-ECLAMPSIA; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM;

ANTIGENS, CD; BIOMARKERS; CARDIOVASCULAR AGENTS; ELECTRON TRANSPORT CHAIN COMPLEX PROTEINS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IN VITRO TECHNIQUES; METFORMIN; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; RECEPTORS, CELL SURFACE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASODILATION;

EID: 84959387273     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2015.12.019     Document Type: Article

References (92)

1. C.W. Redman, and I.L. Sargent Latest advances in understanding preeclampsia Science 308 2005 1592 1594
2. B. Sibai, G. Dekker, and M. Kupferminc Pre-eclampsia Lancet 365 2005 785 799
3. S. Lisonkova, and K.S. Joseph Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease Am J Obstet Gynecol 209 2013 544.e1 544.e12
4. C. Thornton, H. Dahlen, A. Korda, and A. Hennessy The incidence of preeclampsia and eclampsia and associated maternal mortality in Australia from population-linked datasets: 2000-2008 Am J Obstet Gynecol 208 2013 476.e1 476.e5
5. J.R. Barton, J.M. O'Brien, N.K. Bergauer, D.L. Jacques, and B.M. Sibai Mild gestational hypertension remote from term: progression and outcome Am J Obstet Gynecol 184 2001 979 983
6. A.M. Valent, E.A. DeFranco, A. Allison, and et al. Expectant management of mild preeclampsia versus superimposed preeclampsia up to 37 weeks Am J Obstet Gynecol 212 2015 515.e1 515.e8
7. Mol BW, Roberts CT, Thangaratinam S, Magee LA, de Groot CJ, Hofmeyr GJ. Pre-eclampsia. Lancet 2015. Epub ahead of print.
8. N.O. Lunell, R. Lewander, I. Mamoun, L. Nylund, S. Sarby, and S. Thornstrom Uteroplacental blood flow in pregnancy induced hypertension Scand J Clin Lab Invest Suppl 169 1984 28 35
9. S.A. Karumanchi, and Y. Bdolah Hypoxia and sFlt-1 in preeclampsia: the "chicken-and-egg" question Endocrinology 145 2004 4835 4837
10. I. Brosens, R. Pijnenborg, L. Vercruysse, and R. Romero The "Great Obstetrical Syndromes" are associated with disorders of deep placentation Am J Obstet Gynecol 204 2011 193 201
11. M.J. Quinn Preeclampsia: 2 placental phenotypes, 1 etiology? Am J Obstet Gynecol 211 2014 313 314
12. S.J. Fisher Why is placentation abnormal in preeclampsia? Am J Obstet Gynecol 213 2015 S115 S122
13. F.P. McCarthy, J.C. Kingdom, L.C. Kenny, and S.K. Walsh Animal models of preeclampsia; uses and limitations Placenta 32 2011 413 419
14. O. Nevo, N. Soleymanlou, Y. Wu, and et al. Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1 Am J Physiol Regul Integr Comp Physiol 291 2006 R1085 R1093
15. N. Soleymanlou, I. Jurisica, O. Nevo, and et al. Molecular evidence of placental hypoxia in preeclampsia J Clin Endocrinol Metab 90 2005 4299 4308
16. S. Maynard, J.Y. Min, J. Merchan, and et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt-1) may contribute to endothelial dysfunction, hypertension, and proteinuria in pre-eclampsia J Clin Invest 111 2003 649 658
17. S.E. Maynard, and S.A. Karumanchi Angiogenic factors and preeclampsia Semin Nephrol 31 2011 33 46
18. T. Nagamatsu, T. Fujii, M. Kusumi, and et al. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia Endocrinology 145 2004 4838 4845
19. S. Venkatesha, M. Toporsian, C. Lam, and et al. Soluble endoglin contributes to the pathogenesis of preeclampsia Nat Med 12 2006 642 649
20. M.Y. Kim, J.P. Buyon, M.M. Guerra, and et al. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study Am J Obstet Gynecol 214 2016 108.e1 108.e14
21. M.S. Lee, D. Cantonwine, S.E. Little, and et al. Angiogenic markers in pregnancies conceived through in vitro fertilization Am J Obstet Gynecol 213 2015 212.e1 212.e8
22. C.W. Redman, and A.C. Staff Preeclampsia, biomarkers, syncytiotrophoblast stress, and placental capacity Am J Obstet Gynecol 213 2015 S9.e1 S9.e4
23. C.E. Powe, R.J. Levine, and S.A. Karumanchi Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease Circulation 123 2011 2856 2869
24. B.C. Young, R.J. Levine, and S.A. Karumanchi Pathogenesis of preeclampsia Annu Rev Pathol 5 2010 173 192
25. T. Chaiworapongsa, P. Chaemsaithong, L. Yeo, and R. Romero Pre-eclampsia: part 1: current understanding of its pathophysiology Nat Rev Nephrol 10 2014 466 480
26. G.P. Sacks, K. Studena, K. Sargent, and C.W. Redman Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis Am J Obstet Gynecol 179 1998 80 86
27. D.S. Charnock-Jones Placental hypoxia, endoplasmic reticulum stress and maternal endothelial sensitisation by sFLT1 in pre-eclampsia J Reprod Immunol 2015 Epub ahead of print
28. J.M. Roberts, R.N. Taylor, T.J. Musci, G.M. Rodgers, C.A. Hubel, and M.K. McLaughlin Preeclampsia: an endothelial cell disorder Am J Obstet Gynecol 161 1989 1200 1204
29. D. Wright, A. Syngelaki, R. Akolekar, L.C. Poon, and K.H. Nicolaides Competing risks model in screening for preeclampsia by maternal characteristics and medical history Am J Obstet Gynecol 213 2015 62.e1 62.e10
30. J.M. Cohen, M.S. Kramer, R.W. Platt, O. Basso, R.W. Evans, and S.R. Kahn The association between maternal antioxidant levels in midpregnancy and preeclampsia Am J Obstet Gynecol 213 2015 695.e1 695.e13
31. R.O. Bahado-Singh, A. Syngelaki, R. Akolekar, and et al. Validation of metabolomic models for prediction of early-onset preeclampsia Am J Obstet Gynecol 213 2015 530.e1 530.e10
32. A. Sakowicz, P. Hejduk, T. Pietrucha, and et al. Finding NEMO in Preeclampsia Am J Obstet Gynecol 2015 Epub ahead of print
33. J.G. Ray, G.L. Booth, D.A. Alter, and M.J. Vermeulen Prognosis after maternal placental events and revascularization: PAMPER study Am J Obstet Gynecol 214 2016 106.e1 106.e14
34. T.R. Van Veen, R.B. Panerai, S. Haeri, and et al. Cerebral autoregulation in different hypertensive disorders of pregnancy Am J Obstet Gynecol 212 2015 513.e1 513.e7
35. H.D. Major, R.A. Campbell, R.M. Silver, D.W. Branch, and A.S. Weyrich Synthesis of sFlt-1 by platelet-monocyte aggregates contributes to the pathogenesis of preeclampsia Am J Obstet Gynecol 210 2014 547.e1 547.e7
36. T. Chaiworapongsa, P. Chaemsaithong, S.J. Korzeniewski, L. Yeo, and R. Romero Pre-eclampsia part 2: prediction, prevention and management Nat Rev Nephrol 10 2014 531 540
37. B.M. Sibai, B.M. Mercer, E. Schiff, and S.A. Friedman Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks' gestation: a randomized controlled trial Am J Obstet Gynecol 171 1994 818 822
38. K.S. Gibson, T.P. Waters, and J.L. Bailit A risk of waiting: the weekly incidence of hypertensive disorders and associated maternal and neonatal morbidity in low-risk term pregnancies Am J Obstet Gynecol 2015 Epub ahead of print
39. O. Mor, M. Stavsky, M. Yitshak-Sade, and et al. Early onset preeclampsia and cerebral palsy: a double hit model? Am J Obstet Gynecol 214 2016 105.e1 105.e9
40. F.C. Brownfoot, S. Tong, N.J. Hannan, and et al. YC-1 reduces placental sFlt-1 and soluble endoglin production and decreases endothelial dysfunction: a possible therapeutic for preeclampsia Mol Cell Endocrinol 413 2015 202 208
41. S. Rana, A. Rajakumar, C. Geahchan, and et al. Ouabain inhibits placental sFlt1 production by repressing HSP27-dependent HIF-1alpha pathway FASEB J 28 2014 4323 4334
42. A. Rajakumar, and K.P. Conrad Expression, ontogeny, and regulation of hypoxia-inducible transcription factors in the human placenta Biol Reprod 63 2000 559 569
43. K. Kanasaki, K. Palmsten, H. Sugimoto, and et al. Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia Nature 453 2008 1117 1121
44. R. Tal The role of hypoxia and hypoxia-inducible factor-1alpha in preeclampsia pathogenesis Biol Reprod 87 2012 134
45. J.P. Stasch, and O.V. Evgenov Soluble guanylate cyclase stimulators in pulmonary hypertension Handb Exp Pharmacol 218 2013 279 313
46. J.P. Stasch, P. Pacher, and O.V. Evgenov Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease Circulation 123 2011 2263 2273
47. E.J. Yeo, Y.S. Chun, Y.S. Cho, and et al. YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1 J Natl Cancer Inst 95 2003 516 525
48. H. Zhang, D.Z. Qian, Y.S. Tan, and et al. Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth Proc Natl Acad Sci 105 2008 19579 19586
49. J.A. Rowan, W.M. Hague, W. Gao, M.R. Battin, M.P. Moore, and G.T.I. Mi Metformin versus insulin for the treatment of gestational diabetes N Engl J Med 358 2008 2003 2015
50. C.P. Spaulonci, L.S. Bernardes, T.C. Trindade, M. Zugaib, and R.P. Francisco Randomized trial of metformin vs insulin in the management of gestational diabetes Am J Obstet Gynecol 209 2013 34.e1 34.e7
51. J.S. Dhulkotia, B. Ola, R. Fraser, and T. Farrell Oral hypoglycemic agents vs insulin in management of gestational diabetes: a systematic review and metaanalysis Am J Obstet Gynecol 203 2010 457.e1 457.e9
52. S. Jiralerspong, S.L. Palla, S.H. Giordano, and et al. Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer J Clin Oncol 27 2009 3297 3302
53. A. Garcia, and G. Tisman Metformin, B(12), and enhanced breast cancer response to chemotherapy J Clin Oncol 28 2010 e19 e20
54. W.K. Ranasinghe, S. Sengupta, S. Williams, and et al. The effects of nonspecific HIF1alpha inhibitors on development of castrate resistance and metastases in prostate cancer Cancer Med 3 2014 245 251
55. W.W. Wheaton, S.E. Weinberg, R.B. Hamanaka, and et al. Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis eLife 3 2014 e02242
56. S. Andrzejewski, S.P. Gravel, M. Pollak, and J. St-Pierre Metformin directly acts on mitochondria to alter cellular bioenergetics Cancer Metab 2 2014 12
57. K.J. Mather, S. Verma, and T.J. Anderson Improved endothelial function with metformin in type 2 diabetes mellitus J Am Coll Cardiol 37 2001 1344 1350
58. M. Jensterle, M. Sebestjen, A. Janez, and et al. Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome Eur J Endocrinol 159 2008 399 406
59. O. Kruszelnicka, B. Chyrchel, A. Golay, and A. Surdacki Differential associations of circulating asymmetric dimethylarginine and cell adhesion molecules with metformin use in patients with type 2 diabetes mellitus and stable coronary artery disease Amino Acids 47 2015 1951 1959
60. A.E. Caballero, A. Delgado, C.A. Aguilar-Salinas, and et al. The differential effects of metformin on markers of endothelial activation and inflammation in subjects with impaired glucose tolerance: a placebo-controlled, randomized clinical trial J Clin Endocrinol Metab 89 2004 3943 3948
61. R. Austgulen, E. Lien, G. Vince, and C.W. Redman Increased maternal plasma levels of soluble adhesion molecules (ICAM-1, VCAM-1, E-selectin) in preeclampsia Eur J Obstet Gynecol Reprod Biol 71 1997 53 58
62. C.M. Sena, P. Matafome, T. Louro, E. Nunes, R. Fernandes, and R.M. Seica Metformin restores endothelial function in aorta of diabetic rats Br J Pharmacol 163 2011 424 437
63. F.C. Brownfoot, N. Hannan, K. Onda, S. Tong, and T. Kaitu'u-Lino Soluble endoglin production is upregulated by oxysterols but not quenched by pravastatin in primary placental and endothelial cells Placenta 35 2014 724 731
64. T.J. Kaitu'u-Lino, S. Tong, S. Beard, and et al. Characterization of protocols for primary trophoblast purification, optimized for functional investigation of sFlt-1 and soluble endoglin Pregnancy Hypertens 4 2014 287 295
65. American College of Obstetricians and Gynecologists Report of the American College of Obstetricians and Gynecologists' task force on hypertension in pregnancy Obstet Gynecol 122 2013 1122 1131
66. G.J. Burton, N.J. Sebire, L. Myatt, and et al. Optimising sample collection for placental research Placenta 35 2014 9 22
67. F.C. Brownfoot, S. Tong, N.J. Hannan, and et al. Effects of pravastatin on human placenta, endothelium, and women with severe preeclampsia Hypertension 66 2015 687 697 discussion 445
68. A.E. Frazier, and D.R. Thorburn Biochemical analyses of the electron transport chain complexes by spectrophotometry Methods Mol Biol 837 2012 49 62
69. R. Hastie, and M. Lappas The effect of pre-existing maternal obesity and diabetes on placental mitochondrial content and electron transport chain activity Placenta 35 2014 673 683
70. M. Wareing, J.E. Myers, M. O'Hara, and et al. Phosphodiesterase-5 inhibitors and omental and placental small artery function in normal pregnancy and pre-eclampsia Eur J Obstet Gynecol Reprod Biol 127 2006 41 49
71. C.L. Whitehead, K.R. Palmer, U. Nilsson, and et al. Placental expression of a novel primate-specific splice variant of sFlt-1 is upregulated in pregnancies complicated by severe early onset pre-eclampsia BJOG 118 2011 1268 1271
72. S. Senadheera, P.P. Bertrand, T.H. Grayson, and et al. Enhanced contractility in pregnancy is associated with augmented TRPC3, L-type, and T-type voltage-dependent calcium channel function in rat uterine radial artery Am J Physiol Regul Integr Comp Physiol 305 2013 R917 R926
73. M. Baker, S.D. Robinson, T. Lechertier, and et al. Use of the mouse aortic ring assay to study angiogenesis Nat Protoc 7 2012 89 104
74. J. Jebbink, R. Keijser, G. Veenboer, J. van der Post, C. Ris-Stalpers, and G. Afink Expression of placental FLT1 transcript variants relates to both gestational hypertensive disease and fetal growth Hypertension 58 2011 70 76
75. T. Chaiworapongsa, R. Romero, J. Yoshimatsu, and et al. Soluble adhesion molecule profile in normal pregnancy and pre-eclampsia J Matern Fetal Neonatal Med 12 2002 19 27
76. A.M. Borzychowski, I.L. Sargent, and C.W. Redman Inflammation and pre-eclampsia Semin Fetal Neonat Med 11 2006 309 316
77. S. Ahmad, and A. Ahmed Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia Circ Res 95 2004 884 891
78. E. Mills, and L.A. O'Neill Succinate: a metabolic signal in inflammation Trends Cell Biol 24 2014 313 320
79. Y. Takiyama, T. Harumi, J. Watanabe, and et al. Tubular injury in a rat model of type 2 diabetes is prevented by metformin: a possible role of HIF-1alpha expression and oxygen metabolism Diabetes 60 2011 981 992
80. C. Mando, C. De Palma, T. Stampalija, and et al. Placental mitochondrial content and function in intrauterine growth restriction and preeclampsia Am J Physiol Endocrinol Metab 306 2014 E404 E413
81. S. Muralimanoharan, A. Maloyan, J. Mele, C. Guo, L.G. Myatt, and L. Myatt MIR-210 modulates mitochondrial respiration in placenta with preeclampsia Placenta 33 2012 816 823
82. R.J. Levine, S.E. Maynard, C. Qian, and et al. Circulating angiogenic factors and the risk of preeclampsia N Engl J Med 350 2004 672 683
83. Y. Hattori, K. Suzuki, S. Hattori, and K. Kasai Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells Hypertension 47 2006 1183 1188
84. B. Viollet, B. Guigas, N. Sanz Garcia, J. Leclerc, M. Foretz, and F. Andreelli Cellular and molecular mechanisms of metformin: an overview Clin Sci (Lond) 122 2012 253 270
85. P.V. Katakam, M.R. Ujhelyi, M. Hoenig, and A.W. Miller Metformin improves vascular function in insulin-resistant rats Hypertension 35 2000 108 112
86. C. Chiswick, R.M. Reynolds, F. Denison, and et al. Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial Lancet Diabetes Endocrinol 3 2015 778 786
87. E. Vanky, F. de Zegher, M. Diaz, L. Ibanez, and S.M. Carlsen On the potential of metformin to prevent preterm delivery in women with polycystic ovary syndrome: an epi-analysis Acta Obstet Gynecol Scand 91 2012 1460 1464
88. F.C. Brownfoot, N. Hannan, K. Onda, S. Tong, and T. Kaitu'u-Lino Soluble endoglin production is upregulated by oxysterols but not quenched by pravastatin in primary placental and endothelial cells Placenta 35 2014 724 731
89. T.J. Kaitu'u-Lino, S. Tong, S. Beard, and et al. Characterization of protocols for primary trophoblast purification, optimized for functional investigation of sFlt-1 and soluble endoglin Pregnancy Hypertens 4 2014 287 295
90. American College of Obstetricians and Gynecologists Report of the American College of Obstetricians and Gynecologists' task force on hypertension in pregnancy Obstet Gynecol 122 2013 1122 1131
91. A.E. Frazier, and D.R. Thorburn Biochemical analyses of the electron transport chain complexes by spectrophotometry Methods Mol Biol 837 2012 49 62
92. C.L. Whitehead, K.R. Palmer, U. Nilsson, and et al. Placental expression of a novel primate-specific splice variant of sFlt-1 is upregulated in pregnancies complicated by severe early onset pre-eclampsia BJOG 118 2011 1268 1271